Cris Calsada
2020
In 2020, Cris Calsada earned a total compensation of $707.8K as Chief Financial Officer at Regulus Therapeutics, a 134% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,300 |
|---|---|
| Option Awards | $251,176 |
| Salary | $315,000 |
| Other | $9,350 |
| Total | $707,826 |
Calsada received $315K in salary, accounting for 45% of the total pay in 2020.
Calsada also received $132.3K in non-equity incentive plan, $251.2K in option awards and $9.4K in other compensation.
Rankings
In 2020, Cris Calsada's compensation ranked 9,942nd out of 13,090 executives tracked by ExecPay. In other words, Calsada earned more than 24.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,942 out of 13,090 | 24th |
Division Manufacturing | 4,278 out of 5,621 | 24th |
Major group Chemicals And Allied Products | 1,760 out of 2,254 | 22nd |
Industry group Drugs | 1,540 out of 1,954 | 21st |
Industry Pharmaceutical Preparations | 1,136 out of 1,459 | 22nd |
Source: SEC filing on April 30, 2021.
Calsada's colleagues
We found two more compensation records of executives who worked with Cris Calsada at Regulus Therapeutics in 2020.